Tunable Emissive Ir(III) Benzimidazole-quinoline Hybrids as Promising Theranostic Lead Compounds.
Journal Information
Full Title: ChemMedChem
Abbreviation: ChemMedChem
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Conflict of interest The authors declare no conflict of interest."
Funding Disclosure
Evidence found in paper:
"Authors thank the Agencia Estatal de Investigación, projects PID2019‐104379RB‐C21/AEI/10.13039/501100011033, RTI2018‐097836‐J‐I00/MCIN/AEI/10.13039/501100011033/FEDER, RYC2018‐025872‐I (funded by MCIN/AEI/10.13039/501100011033 and by “ESF Investing in your future”), RED2018‐102471‐T/MCIN/AEI/10.13039/501100011033, and Gobierno de Aragón‐Fondo Social Europeo (E07_20R) for financial support. M. R. thanks the Gobierno de Aragón for a predoctoral fellowship."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025